Profit before interest, taxes and amortization: silexion.com (SLXN)

Graphic logo of Silexion Therapeutics (SLXN)

The fierce battle for leadership in targeted oncology is creating the primary market momentum, as clearly demonstrated by the underlying EBITDA, which stands at 0.00. The resilience of Silexion Therapeutics Corp (SLXN) is based on the effectiveness of its fight against KRAS mutations, while management remains focused on validating the functionality of its RNA platforms while awaiting the assessment of clinical test results.

Silexion Therapeutics Corp (SLXN) - Operating profit EBITDA from 11/23/2025 to 11/17/2026

Summary analytical data breakdowns for Silexion (SLXN)

- company stock exchange capitalization indicators:
Analysis of all company metrics:Silexion Therapeutics Corp
Manufactured product of Silexion Therapeutics Corp.

This indicator measures actual cash flow from core operations excluding debt obligations, allowing for the identification of operational risks and declining demand prior to the publication of official financial statements. By analyzing the EBITDA chronology on the GURU.Markets platform, an investor can assess the effectiveness of Silexion Therapeutics Corp. (SLXN) implementing robotic stations and data compilation software systems through the dynamics of real operating profit.

Who Silexion Therapeutics Corp competes with

Income before deduction of interest, taxes and amortization INCY|HCM - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Nuvation Bio Inc|Day One (DAWN) - Profit before payment of interest, taxes and amortization|Operating profit before amortization MNPR|INBX (inhibrx.com) - Operating profit EBITDA|Operating profit before deduction of amortization i-mabbiopharma.com (IMAB)|Profit before payment of interest, taxes and amortization Fennec (FENC)|HRTX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Nuvectis NVCT|Coherus Biosciences - Profit before payment of interest, taxes and amortization|CRBP - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization cardiffoncology.com|BYSI: Operating profit EBITDA|Operating profit before depreciation charges BioAtla, Inc. BCAB|Operating profit before deduction of amortization LIXT|Profit before interest, taxes and amortization Citius Pharmaceuticals, Inc. CTXR|Operating profit before deduction of amortization CLRB (Cellectar Biosciences)|BLRX (BioLineRx) - Income before deduction of interest, taxes and amortization|Can-Fite BioPharma - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization APRE (Aprea)|Kazia Therapeutics Limited - Operating profit EBITDA|Income before deduction of interest, taxes and amortization NCNA (nucana.com)|CMRX: Operating profit EBITDA|Profit before interest, taxes and amortization cyclacel.com (CYCC)|Profit before payment of interest, taxes and amortization g1therapeutics.com|KRON: Income before deduction of interest, taxes and amortization|Operating profit EBITDA KTRA|Operating profit EBITDA Oncternal Corp (ONCT)|Profit before payment of interest, taxes and amortization Portage PRTG